Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
NCT03384563
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The purpose of this protocol is to determine the effect of two clinically applicable Dexmedetomidine dosages (0.5mcg/kg and 1mcg/kg) on the minimum alveolar concentration (MAC) of Sevoflurane in children between the age ranges of: 1-6 months; 6-12 months of age and 12 months-36 months years of age.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Pediatric Anesthesia
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 4
- Ages
- 1 month to 36 months
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Baylor College of Medicine
- Last updated on ClinicalTrials.gov
- September 22, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Texas · 1
- Texas Children's Hospital · Houston, TX
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.